Drug Profile
Research programme: small interfering RNA therapeutics - Lipoxen
Alternative Names: siRNA - Lipoxen; siRNAblate technology - LipoxenLatest Information Update: 15 Sep 2011
Price :
$50
*
At a glance
- Originator Lipoxen Technologies; Unknown
- Developer Unknown; Xenetic Biosciences
- Class Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 03 Jun 2011 Discontinued - Preclinical for Undefined indication in United Kingdom (Parenteral)